03:43 AM EDT, 06/26/2025 (MT Newswires) -- Patrick G Enright, Director, on June 23, 2025, executed a purchase for 250,000 shares in Vera Therapeutics ( VERA ) for $5,277,311. Following the Form 4 filing with the SEC, Enright has control over a total of 3,596,593 Class A common shares of the company, with 3,596,593 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1831828/000095017025090110/xslF345X05/ownership.xml